IFNG and neoplasm: Modified or engineered OMVs have already been used directly as cancer vaccines [14] or to deliver tumor vaccines that induce strong IFN-γ- and T cell-mediated antitumor response, which suggest OMVs have much potential as immunotherapeutic agents [17, 18].